0001209191-20-034676.txt : 20200605
0001209191-20-034676.hdr.sgml : 20200605
20200605160513
ACCESSION NUMBER: 0001209191-20-034676
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200603
FILED AS OF DATE: 20200605
DATE AS OF CHANGE: 20200605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Patricia L
CENTRAL INDEX KEY: 0001348587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 20946136
BUSINESS ADDRESS:
BUSINESS PHONE: 978-687-6988
MAIL ADDRESS:
STREET 1: 7 ASHFORD LANE
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-03
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001348587
Allen Patricia L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2020-06-03
4
M
0
6365
25.73
A
6365
D
Common Stock
2020-06-03
4
S
0
6365
59.1437
D
0
D
Common Stock
2020-06-05
4
M
0
5635
25.73
A
5635
D
Common Stock
2020-06-05
4
S
0
5635
55.9004
D
0
D
Stock Option (Right to Buy)
25.73
2020-06-03
4
M
0
6365
0.00
D
2028-05-16
Common Stock
6365
5635
D
Stock Option (Right to Buy)
25.73
2020-06-05
4
M
0
5635
0.00
D
2028-05-16
Common Stock
5635
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.34, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.09 to $56.00, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This stock option award was issued pursuant to Issuer's 2017 Stock Option and Incentive Plan and vested in full on May 17, 2019, subject to the Reporting Person's continuous service with the Issuer.
/s/ Thomas P. Kelly, Attorney-in-Fact
2020-06-05